BRK-B vs DTF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
DTF exhibits a stable Piotroski F-Score of 6/9, but this is overshadowed by significant valuation and sustainability concerns. The stock is currently trading at $11.44, a notable premium over its Graham Number ($9.49) and Intrinsic Value ($9.74). Most critically, the dividend payout ratio of 118.18% indicates that the fund is returning more capital than it earns, which is unsustainable. Combined with a 0/100 technical trend and negative revenue growth, the outlook is poor despite the high profit margins typical of asset management.
Compare Another Pair
Related Comparisons
BRK-B vs DTF: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and DTF Tax-Free Income 2028 Term Fund Inc. (DTF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.